Abbott Laboratories (ABT)

NYSE - NYSE Real Time Price. Currency in USD
42.83-0.42 (-0.97%)
At close: 4:01 PM EDT

42.83 0.00 (0.00%)
After hours: 4:14 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close43.25
Bid42.80 x 12300
Ask42.81 x 6300
Day's Range42.56 - 43.36
52wk Range36.00 - 46.38
1y Target EstN/A
Market Cap62.96B
P/E Ratio (ttm)28.27
Avg Vol (3m)10,354,632
Dividend & Yield1.04 (2.42%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist4 hours ago

    Johnson & Johnson’s Latest Medical Device Launches

    Johnson & Johnson has announced the schedule for the launch of the OneTouch Via insulin patch. It plans to launch the device in select US markets by the end of 2016.

  • American City Business Journals5 hours ago

    Alere sues Abbott to complete $5.8B merger

    Shares of Waltham-based diagnostics firm Alere are down days after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Alere's shares fell about 4 percent Friday, and have stayed there for the following two days, giving the company a market capitalization of $3.4 billion. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.

  • Bloombergyesterday

    Abbott's Deal Headaches Go Beyond Bad Luck

    Taking the bad with the good on M&A decisions surrounding St. Jude, Alere and Mylan.